Virtus ETF Advisers’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-29,432
| Closed | -$348K | – | 593 |
|
|
2024
Q4 | $348K | Sell |
29,432
-1,035
| -3% | -$12.2K | 0.14% | 201 |
|
|
2024
Q3 | $352K | Hold |
30,467
| – | – | 0.16% | 216 |
|
|
2024
Q2 | $322K | Sell |
30,467
-3,766
| -11% | -$39.8K | 0.16% | 217 |
|
|
2024
Q1 | $361K | Buy |
34,233
+4,925
| +17% | +$51.9K | 0.19% | 207 |
|
|
2023
Q4 | $329K | Sell |
29,308
-2,030
| -6% | -$22.8K | 0.21% | 208 |
|
|
2023
Q3 | $366K | Sell |
31,338
-4,051
| -11% | -$47.3K | 0.22% | 185 |
|
|
2023
Q2 | $357K | Sell |
35,389
-7,271
| -17% | -$73.3K | 0.21% | 148 |
|
|
2023
Q1 | $315K | Buy |
42,660
+755
| +2% | +$5.57K | 0.17% | 194 |
|
|
2022
Q4 | $335K | Sell |
41,905
-21,151
| -34% | -$169K | 0.17% | 227 |
|
|
2022
Q3 | $203K | Buy |
63,056
+927
| +1% | +$2.98K | 0.08% | 318 |
|
|
2022
Q2 | $253K | Buy |
62,129
+43,583
| +235% | +$177K | 0.09% | 296 |
|
|
2022
Q1 | $92K | Sell |
18,546
-1,102
| -6% | -$5.47K | 0.04% | 316 |
|
|
2021
Q4 | $198K | Buy |
+19,648
| New | +$198K | 0.07% | 212 |
|